Clinical Trial: QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07817004) titled 'QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration' on Sept. 02.

Brief Summary: This is a single-center, single-dose, randomized, open-label, crossover study. Forty-two healthy male and female participants will be enrolled. The study will consist of 3 periods in which participants will receive either the test product QLM2010 (18 mL: aprepitant 130 mg and palonosetron hydrochloride 0.25 mg, manufactured by Qilu Pharmaceutical [Hainan] Co., Ltd.) or the Reference Product 1 (aprepitant injection CINVANTI(R), 18 mL: 130 mg, manufactured by Alcami Carolinas Corp.) or the Reference Product 2 (palonosetron ...